. Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence. The Journal of Allergy and Clinical Immunology: in Practice. 2025; 13:S2213-2198(25)00477-5.
. Consensus outcomes between health professionals and parents for oral corticosteroids in treating preschool wheeze: a multi-national survey and nominal group technique study. Sexually Transmitted Infections. 2025; 110:521-527.
. Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 Asthma. Pediatric Pulmonology. 2025; 60:e71197.
. Performance of the Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ) in Assessing Control for Children With Asthma Aged 5 to 11 Years. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a1288.
. Current Practices Among 13 Severe Pediatric Asthma Programs in the United States. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a2249.
. Dupilumab Reduces Exacerbations and Improves Asthma Control in Children Regardless of Asthma Duration. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a1374.
. Epinephrine Prescription and Post-injection Monitoring Practices for Biologic Therapies in Pediatric Severe Asthma Clinics: A Multicenter Survey Analysis. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a2264.
. Performance of the Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ) in Assessing Control Relative to the Pediatric Quality of Life Inventory (PedsQL) and Patient Impression of Control. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a5022.
. Dupilumab plus medium-dose inhaled corticosteroid improves outcomes compared with placebo plus high-dose inhaled corticosteroid in pediatric patients with uncontrolled asthma. Klinische Paediatrie: Zeitschrift fuer Klinik und Praxis. 2025; 237:s2.
. Rémission clinique avec le dupilumab chez les enfants atteints d’asthme de type 2 non contrôlé, modéré à sévère. 2025; 8:84.
. Dupilumab Induces Clinical Remission in Children with Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma. Klinische Paediatrie: Zeitschrift fuer Klinik und Praxis. 2025; 237:s1-s2.
. Race-Specific and Race-Neutral Equations for Lung Function and Asthma Diagnosis in Black Children. JAMA Network Open. 2025; 8:e2462176.
. Performance Of Asthma Control Assessments in Detecting Impairment And Risk In Demographically Diverse Children Aged 5-11 Years. Journal of Allergy and Clinical Immunology. 2025; 155:ab105.
. Outcomes and Recommendations From Telehealth Asthma Clinics in Underserved Schools. Pediatric Pulmonology. 2025; 60:e71003.
. Vitamin D Supplementation, Long-Term PM2.5 Exposure, and Severe Asthma Exacerbations in Children with Low Vitamin D: A Post Hoc Analysis of a Double-Blind, Randomized, Placebo-controlled Trial (VDKA). American Journal of Respiratory and Critical Care Medicine. 2025; 211:266-268.
. Pediatric Asthma Impairment and Risk Questionnaire: Rationale and development of a composite control tool. Annals of Allergy, Asthma, and Immunology. 2025; 134:198-208.e2.
. Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study. Journal of Asthma and Allergy. 2024; 17:143-159.
. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study. Journal of Asthma and Allergy. 2024; 17:81-87.
. Disparities in adolescent controller medication adherence, treatment barriers, and asthma control. Pediatric Pulmonology. 2024; 59:3288-3297.
. DUPILUMAB PLUS MEDIUM-DOSE INHALED CORTICOSTEROID IMPROVES OUTCOMES COMPARED WITH PLACEBO PLUS HIGH-DOSE INHALED CORTICOSTEROID IN PEDIATRIC PATIENTS WITH UNCONTROLLED ASTHMA. Chest. 2024; 166:a4806-a4808.
. Impulse oscillometry: Gathering speed in the assessment of preschool lung function. Journal of Allergy and Clinical Immunology. 2024; 154:82-83.
. Efficacy of oral corticosteroids for acute preschool wheeze: a systematic review and individual participant data meta-analysis of randomised clinical trials. The Lancet Respiratory Medicine. 2024; 12:444-456.
. Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study. The Journal of Allergy and Clinical Immunology: in Practice. 2024; 12:948-959.
. Climate Change and Children's Health: Building a Healthy Future for Every Child. Pediatrics. 2024; 153:e2023065505.
. Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study). Pediatric Allergy and Immunology. 2024; 35:e14092.
. Long-term dupilumab effect on lung function in paediatric patients with uncontrolled asthma. Pneumologie. 2024; 78:s7.
. Long-term dupilumab effect on lung function in paediatric patients with uncontrolled asthma. Klinische Paediatrie: Zeitschrift fuer Klinik und Praxis. 2024; 236:s2-s3.
. Effet à long terme du dupilumab sur la fonction respiratoire chez des patients pédiatriques souffrant d’asthme non contrôlé. Revue des Maladies Respiratoires Actualites. 2024; 16:185.
. Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study. The Lancet Respiratory Medicine. 2024; 12:45-54.
. LONG-TERM DUPILUMAB EFFECT ON LUNG FUNCTION IN MULTIPLE SUBGROUPS OF PEDIATRIC PATIENTS WITH UNCONTROLLED ASTHMA. Chest. 2023; 164:a40-a44.
. Long-Term Exposure to Particulate Matter <2.5 μm and Lung Function Change in Children with Asthma Receiving Inhaled Corticosteroids. American Journal of Respiratory and Critical Care Medicine. 2023; 208:622-624.
. How Has the Biologic Revolution Improved Patient Care?. The Journal of Allergy and Clinical Immunology: in Practice. 2023; 11:2683-2685.
. Children with uncontrolled asthma from economically disadvantaged neighborhoods: Needs assessment and the development of a school-based telehealth and electronic inhaler monitoring system. Pediatric Pulmonology. 2023; 58:2249-2259.
. Questions in Mild Asthma: An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 2023; 207:e77-e96.
. Technology-Assisted Stepped-Care to Promote Adherence in Adolescents with Asthma: A Pilot Study. Journal of Clinical Psychology in Medical Settings. 2023; 30:415-424.
. Impact Of Exacerbation History On Dupilumab Efficacy In Children With Asthma In The VOYAGE Study. Journal of Allergy and Clinical Immunology. 2023; 151:ab19.
. Long-Term Dupilumab Treatment Effect On Safety And Clinical Efficacy In Children With Type 2 Asthma: LIBERTY ASTHMA EXCURSION. Journal of Allergy and Clinical Immunology. 2023; 151:ab15.
. Asthma Management in Children. The Journal of Allergy and Clinical Immunology: in Practice. 2023; 11:9-18.
. Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma. npj Primary Care Respiratory Medicine. 2022; 32:31.
. ASSESSMENT OF THE LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA (LIBERTY ASTHMA EXCURSION STUDY). Chest. 2022; 162:a2677-a2679.
. Violence-related distress and lung function in two longitudinal studies of youth. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2022; 59:2102329.
. Treatment by biomarker-informed endotype vs guideline care in children with difficult-to-treat asthma. Annals of Allergy, Asthma, and Immunology. 2022; 128:535-543.e6.
. Key Issues in Pediatric and Adult Severe Asthma: Staying Grounded as Biologics Take Us to New Heights. The Journal of Allergy and Clinical Immunology: in Practice. 2022; 10:420-421.
. Effect of vitamin D supplementation on total and allergen-specific IgE in children with asthma and low vitamin D levels. Journal of Allergy and Clinical Immunology. 2022; 149:440-444.e2.
. Evaluation of Risk Scores to Predict Pediatric Severe Asthma Exacerbations. The Journal of Allergy and Clinical Immunology: in Practice. 2021; 9:4393-4401.e8.
. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2021; 58:2100989.
. Feasibility and preliminary validity of mobile spirometry in pediatric asthma. The Journal of Allergy and Clinical Immunology: in Practice. 2021; 9:3821-3823.
. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: the VDKA randomized clinical trial. 2021.
. Which Wheezing Preschoolers Should be Treated for Asthma?. The Journal of Allergy and Clinical Immunology: in Practice. 2021; 9:2611-2618.
. Use of the composite asthma severity index in a pediatric subspecialty clinic. Annals of Allergy, Asthma, and Immunology. 2021; 126:702-706.
. 129Xe MRI as a measure of clinical disease severity for pediatric asthma. Journal of Allergy and Clinical Immunology. 2021; 147:2146-2153.e1.
. Nasal DNA methylation differentiates severe from non-severe asthma in African-American children. Allergy: European Journal of Allergy and Clinical Immunology. 2021; 76:1836-1845.
. Bronchial Thermoplasty. Diagnostic and Interventional Bronchoscopy in Children. : Springer Nature; Springer Nature; 2021.
. Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemporary Clinical Trials. 2021; 100:106228.
. Exciting Era of Sensor-Based Electronic Monitoring of Adherence in Pediatric Asthma. Pediatrics. 2021; 147:e2020036749.